Author:
Fleetcroft Robert,Schofield Peter,Ashworth Mark
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. World Health Organisation: The 10 leading causes of death by broad income group (2008). Fact sheet No 310. 2012, Geneva
2. Cholesterol Treatment Trialists' (CTT) Collaborators: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012, 380 (9841): 581-590.
3. Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N: A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess. 2007, 11 (14): 1-160. iii-iv
4. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010, 121 (4): 586-613. 10.1161/CIRCULATIONAHA.109.192703.
5. National Institute for Health and Care Excellence: CG67 Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease: full guideline. 2008, London
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献